Digital Therapeutics Leader Pear Therapeutics Announces Expanded Support to Point32Health Members in Recovery from Substance Use Disorders

Early on in 2022, digital therapeutics continue to see adoption with payers. Digital Therapeutics Leader Pear Therapeutics Announces Expanded Support to Point32Health Members in Recovery from Substance Use Disorders. Digital Health News

Embold Health Raises $20M Series B to Focus on National Expansion

Embold Health, a leader in objective physician performance analytics, announced a Series B investment led by Echo Health Ventures. The $20M Series B investment will allow Embold Health to focus on national expansion and advance the vision to raise health care quality by providing every health care consumer in America with actionable, objective quality metrics. 

Therapixel mammoscreen

Therapixel Receives FDA Clearance for AI-Based Breast Cancer Screening Software MammoScreen® on 3D Mammography

Therapixel has announced it has received a second 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its explainable and actionable Artificial Intelligence (A.I.) based software assisting Radiologists in breast cancer screening, MammoScreen®. This new 510(k) (K211541) expands the use of Mammoscreen® to Digital Breast Tomosynthesis (or 3D Mammography).

Babyscripts Virtual Maternity Care Funding

Babyscripts Raises Additional $7.5M for Virtual Maternity Care National Expansion

Maternal health startup Babyscripts, which makes an app for expectant mothers, has raised another $7.5 million in a Series B round. This additional funding brings this latest haul to $19.5 million, after the $12 million it secured in September. Babyscripts expects to use this extra funding to continue building out its platform, Babyscripts Virtual Maternity Care, a tool that tracks a patient’s pregnancy and postpartum information at each stage.